Background-Mice
A therosclerosis is a chronic inflammatory disease of the arterial vessel wall that progresses from fatty streak to fibrofatty matrix and fibrous plaque. Monocyte recruitment to the vessel wall and transformation to lipid-enriched foam cells initiate and sustain atherosclerosis. 1 12/15-Lipoxygenase (12/15-LO) is a nonheme ironcontaining dioxygenase that forms 12-hydroperoxyeicosatetraenoic acid (12-HPETE) and 15-HPETE and oxidizes esterified fatty acids in lipoproteins (cholesteryl esters) and phospholipids. 2, 3 On the basis of its product from arachidonic acid, it is classified as 15-lipoxygenase (15-LO) in humans and rabbits 4, 5 and as "leukocyte-type" 12-lipoxygenase (12-LO) in pig, rat, and mouse. 6 12/ 15-LO can also produce 13-hydroperoxy-octadecadienoic acid (13-HPODE) from linoleic acid. 2, 3 Mouse leukocyte 12/15-LO is highly related to 15-LO in humans in that they are Ϸ74% identical in primary structure, and both are dual-specificity lipoxygenases. 7 Mouse 12/15-LO probably represents the orthologue of 15-LO in humans. 3, 7 Pharmacological inhibition of 15-LO in hypercholesterolemic rabbits resulted in attenuation of atherosclerosis. 8, 9 In the apoE Ϫ/Ϫ , LDLR Ϫ/Ϫ , and apobec-1 Ϫ/Ϫ /LDL-R Ϫ/Ϫ mouse models of atherosclerosis, disruption of the 12/ 15-LO gene significantly retarded the initiation and progression of atherosclerosis. 10 -12 A variety of vascular cells are able to express 12/15-LO, including endothelial cells, 13, 14 smooth muscle cells, 13, 14 and monocytes/macrophages. 13, 15 Overexpression of 12/15-LO in mouse endothelial cells 16 and rabbit monocytes/macrophages 17 resulted in completely opposite effects: The former was proatherogenic and the latter antiatherogenic, which indicates a possibility that different cellular expression of 12/15-LO may have different effects on atherosclerosis or that species differences may exist.
In the present study, we used bone marrow transfer to determine the role of 12/15-LO in macrophages and vascular cells (including endothelial cells and smooth muscle cells) in the development of atherosclerosis. We also examined the effects of 12/15-LO on endothelial activation and monocyte adhesion using in vitro endothelium-monocyte interaction systems. Finally, we compared in vitro foam cell formation in bone marrow-derived and peritoneal macrophages isolated from 12/15-LO Ϫ/Ϫ or wild-type mice.
Methods

Mice: Bone Marrow Transplantation
The generation and genotype analysis of 12/15-LO Ϫ/Ϫ /apoE Ϫ/Ϫ mice have been described previously. 10 Mouse bone marrow transplantation (BMT) was performed as described previously. 18 Four weeks after recovery from BMT, mice were fed a Western diet for 12 weeks.
Determination of 12/15-LO mRNA Expression With Real-Time Reverse TranscriptionPolymerase Chain Reaction
Total RNA was isolated with an RNeasy Mini Kit (Qiagen Inc). The primers used to analyze mRNA for mouse 12/15-LO were CTCT-CAAGGCCTGTTCAGGA (sense) and GTCCATTGTCCCCA-GAACCT (antisense). Reverse transcription-polymerase chain reaction (RT-PCR) was performed on the iCycler (Bio-Rad Laboratories) with SYBR Green I (Molecular Probes).
Preparation of Mouse Aortas and Quantification of Atherosclerosis
The aortas of mice were collected and stained with oil red O. 19 Images were scanned into a Macintosh computer, and the percent surface areas occupied by lesions were determined with ImageProPlus (Media Cybernetics).
Measurement of Plasma Lipids, Isoprostanes, and Autoantibody Titers Against Oxidized LDL Epitopes
Plasma triglyceride and total cholesterol levels were determined via an automated enzymatic technique (Boehringer Mannheim GmbH). Plasma 8,12-iso-iPF␣-VI levels were measured by gas chromatography/mass spectrometry. 11 The titers of IgG and IgM autoantibodies against malondialdehyde LDL (MDA-LDL) and oxidized LDL (OxLDL) were analyzed as described previously. 20 
Isolation and Culture of Murine Aortic Endothelial Cells and Macrophages
Endothelial cells from mouse thoracic aortas were isolated and cultured as described previously. 21 Endothelial cells from passage 3 to 5 were used in this study. Macrophages used in this study were either harvested by peritoneal lavage or differentiated from bone marrow cell by cytokines that included interleukin-4 (IL-4), granulocyte-macrophage colony-stimulating factor (GM-CSF), and macrophage colony-stimulating factor (M-CSF).
Monocyte Adhesion Assay
Confluent murine endothelial monolayers were washed and cultured in serum-free DMEM supplemented with Nutridoma-HU (Roche Diagnostics GmbH). LDL (Biomedical Technologies, Inc) was added at a final concentration of 200 g/mL. After 20 hours, cell media were removed, and the endothelial monolayer was washed 3 times for the monocyte adhesion assay. The confluent murine endothelial monolayer was cocultured with macrophages for 24 hours in serum-free DMEM supplemented with Nutridoma-HU in the presence of LDL at a concentration of 200 g/mL. Then, washed endothelial monolayers were incubated with 10 6 carboxyfluorescein diacetate succinimidyl ester-labeled WEHI78/24 cells (a murine monocytic cell line) suspended in 1 mL of binding buffer for 20 minutes. After a vigorous wash, adherent cells were determined by fluorescence intensity.
In Vitro Foam Cell Assay
Thioglycollate-elicited or bone marrow-derived macrophages were used. For some experiments, macrophages were stimulated with IL-4. LDL, OxLDL, or acetylated LDL (Biomedical Technologies, Inc) was added at different concentrations for different periods. Then, macrophages were washed with PBS, fixed with 4% paraformaldehyde, and stained with oil red O. Images were scanned into a Macintosh computer, and the percentage of oil red O-positively stained cells or surface area occupied by oil red O-stained droplets in each cell was determined with Image-Pro Plus.
Statistical Analysis
Statistical analysis was performed with Instat software (GraphPad Software). Data are represented as meanϮSE. Data were compared with either 1-way ANOVA followed by Bonferroni correction post hoc test or Student t test to evaluate 2-tailed levels of significance. The null hypothesis was rejected at PϽ0.05.
Results
Expression of 12/15-LO mRNA In Vivo
To investigate potential tissue-specific roles of 12/15-LO in atherosclerosis, we first surveyed 12/15-LO mRNA expression in atherosclerotic mice using real-time RT-PCR. Of all tissues surveyed, the highest mRNA expression level was found in peritoneal macrophages. 12/15-LO mRNA in elicited peritoneal macrophages was Ϸ1000 times higher than that in other tissues, including lung, heart, atherosclerotic vessel, liver, gut, spleen, lymph node, kidney, and adipose tissue. 12/15-LO was undetectable in brain and muscle (Figure 1 
Role of Bone Marrow-Derived 12/15-LO in Atherosclerosis
Bone marrow-derived macrophages contribute to foam cell formation in atherosclerotic lesions. 22 To determine Mean cholesterol and triglyceride levels in bone marrowtransferred mice in different groups were not different (data not shown). Because the apoE Ϫ/Ϫ mice reconstituted with bone marrow from 12/15-LO Ϫ/Ϫ /apoE Ϫ/Ϫ mice had small atherosclerotic lesions, indistinguishable from the lesion size found in mice completely lacking 12/15-LO, we tested whether plasma 8,12-iso-iPF 2␣ -VI levels in these mice would also be suppressed. Interestingly, isoprostane levels in these mice were the same as in apoE Ϫ/Ϫ or 12/15-LO Ϫ/Ϫ /apoE Ϫ/Ϫ mice reconstituted with the bone marrow of apoE Ϫ/Ϫ mice (Figure 3a) . In atherosclerosis, an immune response to oxidized lipids is prominent and results in the formation of autoantibodies of the IgM and IgG isotypes to modified LDL. 23 In all groups of BMT mice, autoantibody levels, especially levels of IgG autoantibodies, were much lower than those of age-matched controls, presumably because the immune system had not completely recovered from the lethal irradiation and reconstitution at the time serum was harvested. Interestingly, autoantibody (IgM Ab against copper-modified LDL) levels were higher in mice reconstituted with the bone marrow of apoE Ϫ/Ϫ mice than in those receiving the bone marrow of 12/15-LO Ϫ/Ϫ /apoE Ϫ/Ϫ mice, irrespective of the genotype of the recipient ( Figure  3b ). Consistent with protection of mice receiving 12/15-LO Ϫ/Ϫ /apoE Ϫ/Ϫ bone marrow, we found a highly significant positive correlation of autoantibody (IgM Ab against copper-modified LDL) levels with lesion size (Figure 3c ). Autoantibody levels did not correlate with levels of plasma isoprostanes (Figure 3d ).
Endothelial Activation by Autocrine 12/15-LO Products
Aortic endothelium of apoE Ϫ/Ϫ mice fed a Western diet is activated and expresses various adhesion molecules. 24 Because endothelial cells are known to express 12/15-LO, 13 we tested whether endothelial activation is caused by endothelial cell 12/15-LO by an autocrine mechanism. 
Endothelial Activation by Macrophage 12/15-LO Activity
To test whether macrophage 12/15-LO has an influence in endothelial activation and endothelium-monocyte interactions, we developed a coculture system (Figure 5a ) in which peritoneal macrophages from 12/15-LO Ϫ/Ϫ or wildtype mice were incubated in the upper well of a transwell system with and without native (nonmodified) LDL, and endothelial cells in the lower well were used as indicators of endothelial activation, measured by adhesion of WEHI78/24 cells. In the absence of LDL, neither wildtype nor 12/15-LO-deficient macrophages induced much endothelial activation (Figures 5b and 5c) . By contrast, when LDL was added to the culture media, wild-type but not 12/15-LO-deficient macrophages had a large and significant activating effect on endothelial cells, as demonstrated by a 3-fold elevation of WEHI78/24 cell adhesion (Figures 5b and 5c ) and significant upregulation of VCAM-1 on endothelial cells (Figures 5d and 5e ). 
Foam Cell Formation by 12/15-LODeficient Macrophages
Foam cell formation is a hallmark of atherosclerosis. 25 Therefore, we tested whether 12/15-LO might influence foam cell formation in peritoneal macrophages loaded with acetylated LDL. After 24 and 48 hours in culture, oil red O uptake as a marker of lipid accumulation was indistinguishable in macrophages from wild-type and 12/15-LO Ϫ/Ϫ mice (Figure 6a) . Similar results were obtained with OxLDL (data not shown).
When 12/15-LO-deficient peritoneal macrophages were cultured in the presence of native LDL, their lipid uptake was much reduced compared with wild-type controls. The intensity of oil red O staining was decreased in peritoneal macrophages from 12/15-LO Ϫ/Ϫ mice (Figures 6b and 6c) . The difference was further enhanced in macrophages stimulated with IL-4 (Figures 6b and 6c) . This may be due to an increase of 12/15-LO protein and activity induced by IL-4 in vitro. 26 Similar results were obtained on macrophages differentiated from bone marrow cells in the presence of GM-CSF, IL-4, and M-CSF (data not shown).
Discussion
Our study demonstrates that 12/15-LO in macrophages is critical for the formation of atherosclerotic lesions. Mice reconstituted with bone marrow from apoE Ϫ/Ϫ /12/15-LO Ϫ/Ϫ mice show Ͼ50% reduced lesion sizes compared with mice receiving apoE Ϫ/Ϫ bone marrow. Double-knockout mice regained the severity of atherosclerotic lesion typical of apoE Ϫ/Ϫ mice after receiving bone marrow from apoE Ϫ/Ϫ mice. Thus, macrophage 12/15-LO mediates endothelial activation and foam cell formation, 2 key steps in the process of atherosclerosis. The BMT study suggests that macrophage 12/15-LO is proatherogenic in mice. This is inconsistent with previous studies by Shen et al, 17 who found that 15-LO in monocytes/macrophages is antiatherogenic in a rabbit atherosclerotic model. The conflicting conclusions from these studies may be due to differences in species (rabbit versus mouse), lipoxygenase gene products (ratio of 12HETE:15HETE), and genetic manipulation (knockout versus transgenic overexpression). The expression level of the enzyme in transgenic monocyte-derived rabbit macrophages is Ͼ20-fold higher than in macrophages of normal rabbits and comparable to that of highly activated human monocytes by cytokines. 27 12/15-LO and its products at high concentrations may play a role different from that at their physiological concentration. Recent studies have shown that several 12/15-LO products are ligands of peroxisome proliferator-activated receptor-␥ (PPAR␥). 28 PPAR␥ ligands have potent antiinflammatory effects at a high concentration. 29 Overexpression of 15-LO in monocytes/macrophages may result in substantial accumulation of 12/15-LO products and consequently trigger the PPAR␥ pathway in these cells.
Circulating precursor cells can be recruited to the vessel wall and differentiate to various vascular cells under different pathological conditions, especially in the setting of vascular injury. 30 In spontaneous atherosclerotic vessels, only a very limited number of endothelial cells and smooth muscle cells are replaced by differentiated donorderived stem cells within 8 to 12 weeks after BMT. 30 In the same time frame, 12/15-LO Ϫ/Ϫ /apoE Ϫ/Ϫ mice receiving bone marrow from apoE Ϫ/Ϫ mice developed the same extent of atherosclerotic lesions as control mice. There- fore, the contribution of circulating precursor cells to the observed effects, if there is any, is likely to be small.
Human monocytes and macrophages express a 15-LO that can also produce 12-HETE and probably represents the human orthologue of mouse 12/15-LO. 3 The presence of specific 15-lipoxygenase products, 31 15 -LO protein and 15-LO mRNA, 32 in human atherosclerotic arteries has been clearly demonstrated in samples obtained from patients aged 15 to 37 years. In a recent report, Spanbroek et al 33 did not detect 15-LO in very advanced atherosclerotic arterial samples. The present study was performed at the time when mice start to develop atherosclerosis, showing participation of macrophage 12/15-LO in the early phase of atherogenesis in mice, which is consistent with the findings in humans.
In the absence of LDL, macrophage 12/15-LO causes little increase in endothelial activation. However, in the presence of LDL, macrophage 12/15-LO significantly increases expression of endothelial adhesion molecules and endothelial-monocyte interactions. A suppression of lipid uptake and foam cell formation in macrophages lacking 12/15-LO was observed after incubation with native LDL but not modified LDL. 12 These results suggest that the proatherogenic role of macrophage 12/15-LO may be related to its oxidative action on LDL. 10 -12 However, in this BMT study, levels of isoprostane do not correlate with the sizes of atherosclerotic lesions. Overall levels of isoprostane may not reflect the local accumulation of oxidative products generated by 12/15-LO in the vessel wall, which may be important for the formation of atherosclerotic lesions. Alternatively, other 12/15-LO-dependent mechanisms may be involved. A recent study has demonstrated a decrease in production of IL-12 in 12/15-LO-deficient macrophages, 34 which suggests a reduced immune response. This correlates with lower titers of autoantibodies to OxLDL in BMT mice in the present study. Therefore, in addition to its oxidative action, macrophage-derived 12/15-LO may also be involved in regulating the immune response during initiation and progression of atherosclerosis.
